.jpg)
The ministry of civil aviation has disagreed with a proposal of the Prime Minister's Office to explore raising the cap on the number of weekly flights from Qatar in exchange for discounts on additional supplies of liquefied natural gas from there.
Move follows a spate of international regulatory enforcements on Indian drug firms.
Importers protest as food safety regulator demands adherence to recent law on labelling, blocks entry at ports for packs with stickers.
Govt wants firms to remove suffixes & prefixes to original names of these drugs.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
Say heavy penalties for medical errors might raise health care costs and make practitioners too cautious, says Sushmi Dey
Following the entry of Tata-SIA and AirAsia into the Indian aviation market, the domestic aviation industry is seeing increased interest from private entities.
As many as 150 applications are stuck at evaluation stage, says official.
To sell five Boeing 777s, replacing these with cheaper aircraft
Ranbaxy's US factory, Ohm Laboratories, is learnt to have got a clean chit from the American regulator. This US facility was under surveillance of the Food and Drug Administration (FDA) since the end of 2012.
Happy hours, a discount concept popular across bars, restaurants and multiplexes, is now catching up in the health care sector, too.
Norms limiting airlines' stake in SPVs managing airports to hurt Tatas.
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
While four of the directors would be nominated by Tata Sons, the other two would be representatives of Singapore Airlines.
Singapore Airlines first approached the Tatas, its old choice for a venture in India, and was aware of AirAsia negotiations.
Tata-SIA will kick off with full-service domestic operations.
AirAsia says deal not violative of shareholder agreement.
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
The move comes in the wake of many facilities of Ranbaxy in India being barred by the US Food and Drugs Administration for supplying medicines to the US.
The national carrier has drawn a blueprint to cut the number of recognised unions in the airline from 15 to two -- one for pilots and another for the rest of the employees.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances